BAGSVAERD DENMARK–(Marketwire – Dec 25, 2012) – Company announcement No 84 / 2012: http://hugin.info/2013/R/1667087/541141.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1667087]
Marketwire News Archive – Yahoo! Finance
Title Post: Novo Nordisk A/S: Ryzodeg(R) (insulin degludec/insulin aspart) approved in Japan
Rating:
100%
based on 99998 ratings.
5 user reviews.
Author:
Thanks for visiting the blog, If any criticism and suggestions please leave a comment
Novo Nordisk A/S: Ryzodeg(R) (insulin degludec/insulin aspart) approved in Japan
This article
Novo Nordisk A/S: Ryzodeg(R) (insulin degludec/insulin aspart) approved in Japan
can be opened in url
http://artofspadez.blogspot.com/2012/12/novo-nordisk-as-ryzodegr-insulin.html
Novo Nordisk A/S: Ryzodeg(R) (insulin degludec/insulin aspart) approved in Japan
